......... 52 Heat Biologics, Inc. Investigational Product: Viagenpumatucel -L Protocol HS110 -201 CONFIDENTIAL Version 4.0; 29 -Oct-2014 Page 15 of 84 7.5.2 Prohibited Medications ................................ ................................